WHO Adds Breakthrough Cancer and Diabetes Drugs to Essential List

Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.

Written & Supervised By
Preventive Medicine and Public Health Specialist | 40+ Years Experience

Medically Reviewed
Dr. Jose Rossello, MD, PhD, MHCM
Preventive Medicine & Public Health Specialist
Last Reviewed: September 23, 2025

The World Health Organization has updated its Essential Medicines Lists, adding key new treatments for cancer and diabetes, including GLP-1 receptor agonists and rapid-acting insulins for type 2 diabetes with obesity or related conditions. These lists guide medicine procurement and health coverage in over 150 countries, aiming to improve global access to effective, affordable therapies. This update also includes medicines for cystic fibrosis, psoriasis, haemophilia, and blood disorders, reflecting evolving public health needs and expanding options for preventive and chronic disease management.

Source: Who Releases

🏛️ Read official report[1]

Date: September 23, 2025

  1. Who’s Really Responsible for Poor Diets in the UK? Beyond Individual Blame
  2. Addressing Colorectal Cancer Screening Gaps in People with IDD: Caregiver Insights
  3. Heart-Healthy Eating in Youth: Proven Diet Gains and Health Benefits
  4. Global Impact of Low Bone Density: Prevent Fractures & Costs

References

  1. WHO updates list of essential medicines to include key cancer, diabetes treatments. Accessed November 7, 2025
author avatar
Jose Rossello, MD, PhD, MHCM
Dr. Rossello is a medical doctor specializing in Preventive Medicine and Public Health. He founded PreventiveMedicineDaily.com to provide evidence-based health information supported by authoritative medical research.
See Full Bio
Previous
Next
Leave a Comment

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}